Security Snapshot

Brainsway Ltd. - American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share (BWAY) Institutional Ownership

CUSIP: 10501L106

13F Institutional Holders and Ownership History from Q2 2019 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

54

Shares (Excl. Options)

11,694,548

Price

$13.29

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share
Symbol
BWAY on Nasdaq
Shares outstanding
40,069,408
Price per share
$13.29
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
11,694,548
Total reported value
$155,381,808
% of total 13F portfolios
0.01%
Share change
+5,793,191
Value change
+$76,061,864
Number of holders
54
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • BWAY - Brainsway Ltd. - American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share is tracked under CUSIP 10501L106.
  • 54 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 43 to 54 between Q4 2025 and Q1 2026.
  • Reported value moved from $112,583,392 to $155,381,808.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 54 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 10501L106?
CUSIP 10501L106 identifies BWAY - Brainsway Ltd. - American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

Significant Owners of Brainsway Ltd. - American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share (BWAY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Valor BrainsWay Holdings, LLC 15% -21% $88,184,187 -$28,521,524 5,851,444 -24% Jonathan Shulkin 06 Oct 2025
MEITAV INVESTMENT HOUSE LTD 5.2% $28,912,001 2,099,637 MEITAV INVESTMENT HOUSE LTD 31 Mar 2026
Harel Insurance Investments & Financial Services Ltd. 5.2% $48,968,153 1,981,714 Harel Insurance Investments & Financial Services Ltd 16 Feb 2026
Hagai Avner 4.7% $16,784,164 1,772,351 Avner Hagai 28 Jan 2025

As of 31 Mar 2026, 54 institutional investors reported holding 11,694,548 shares of Brainsway Ltd. - American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share (BWAY). This represents 29% of the company’s total 40,069,408 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Brainsway Ltd. - American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share (BWAY) together control 28% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Valor Management LLC 13% 5,314,950 +100% 39% $70,635,686
MASTERS CAPITAL MANAGEMENT LLC 4.1% 1,650,000 +65% 3.2% $21,928,500
ACADIAN ASSET MANAGEMENT LLC 2% 818,272 +100% 0.02% $10,859,000
ESSEX INVESTMENT MANAGEMENT CO LLC 1.5% 618,553 +103% 1.3% $8,220,569
RENAISSANCE TECHNOLOGIES LLC 1.3% 518,420 +87% 0.01% $6,889,802
Cresset Asset Management, LLC 0.79% 314,924 +100% 0.02% $4,185,340
Y.D. More Investments Ltd 0.68% 272,004 +137% 0.14% $3,614,933
SEI INVESTMENTS CO 0.56% 226,378 +262% 0% $3,008,564
ARK Investment Management LLC 0.48% 193,686 +52% 0.02% $2,574,087
Legato Capital Management LLC 0.48% 192,150 +97% 0.23% $2,553,673
EAGLE GLOBAL ADVISORS LLC 0.43% 172,606 +112% 0.08% $2,293,934
TWO SIGMA INVESTMENTS, LP 0.32% 128,187 +69% 0% $1,703,605
GOLDMAN SACHS GROUP INC 0.27% 107,712 +318% 0% $1,431,492
MORGAN STANLEY 0.26% 104,394 +126% 0% $1,387,396
ROYCE & ASSOCIATES LP 0.24% 97,033 0.01% $1,289,569
CITADEL ADVISORS LLC 0.22% 87,053 +236% 0% $1,156,934
UBS Group AG 0.2% 82,142 +143% 0% $1,091,668
Huntleigh Advisors, Inc. 0.2% 81,519 -6.4% 0.19% $1,083,389
Trexquant Investment LP 0.19% 77,154 +499% 0.01% $1,025,377
Quadrature Capital Ltd 0.19% 76,443 +410% 0.01% $1,015,927
Sigma Planning Corp 0.18% 70,363 +369% 0.03% $935,124
JANE STREET GROUP, LLC 0.14% 57,973 0% $770,461
WELLS FARGO & COMPANY/MN 0.14% 56,156 +179% 0% $746,313
JPMORGAN CHASE & CO 0.12% 47,030 +107% 0% $600,103
Bullseye Asset Management LLC 0.1% 41,482 +164% 0.32% $551,000

Institutional Holders of Brainsway Ltd. - American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share (BWAY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 11,694,548 $155,381,808 +$76,061,864 $13.29 54
2025 Q4 5,919,023 $112,583,392 +$10,199,350 $19.02 43
2025 Q3 5,418,805 $81,646,480 -$4,085,043 $15.07 44
2025 Q2 5,756,595 $75,688,047 -$2,911,475 $13.15 42
2025 Q1 5,985,628 $56,672,895 +$352,891 $9.47 42
2024 Q4 5,948,448 $56,116,218 +$24,680,508 $9.43 39
2024 Q3 3,272,103 $30,224,585 -$2,808,569 $9.24 32
2024 Q2 3,580,609 $21,724,387 -$710,233 $6.07 27
2024 Q1 3,742,213 $19,793,669 -$3,510,811 $5.29 29
2023 Q4 4,324,577 $28,707,600 +$1,908,696 $6.48 27
2023 Q3 4,030,044 $16,275,747 -$87,587 $4.04 15
2023 Q2 4,096,728 $9,333,991 +$1,395,901 $2.28 16
2023 Q1 3,809,805 $6,680,005 -$4,119,118 $1.76 13
2022 Q4 5,267,128 $12,999,985 -$4,442,384 $2.47 16
2022 Q3 7,049,001 $25,750,669 -$158,551 $3.61 16
2022 Q2 7,083,237 $34,539,274 -$1,444,443 $4.83 18
2022 Q1 7,191,154 $62,732,800 +$699,100 $8.73 18
2021 Q4 7,145,219 $55,003,756 +$554,746 $7.70 22
2021 Q3 7,073,690 $56,952,820 -$5,913,303 $8.06 18
2021 Q2 7,605,352 $77,572,145 +$3,146,974 $10.20 22
2021 Q1 7,344,898 $66,329,030 +$44,135,746 $9.03 23
2020 Q4 1,901,571 $14,325,000 -$447,918 $7.54 8
2020 Q3 1,979,558 $11,431,000 +$108,201 $5.83 11
2020 Q2 1,951,565 $11,470,000 +$45,218 $5.92 11
2020 Q1 1,878,792 $14,846,000 +$1,106,559 $7.94 11
2019 Q4 1,396,118 $13,595,000 +$1,304,166 $9.76 11
2019 Q3 1,216,311 $10,961,000 +$86,361 $9.13 8
2019 Q2 1,173,281 $12,221,000 +$12,221,000 $10.47 11
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .